---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-272890"
form_type: "8-K"
ticker: "CGEM"
cik: "0001789972"
company_name: "Cullinan Therapeutics, Inc."
filed_at: "2026-06-16T21:18:15+00:00"
generated_at: "2026-06-16T21:20:31.677382+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Cullinan Therapeutics reports annual meeting results; all proposals approved

## Summary
- Shareholders elected Nadim Ahmed and Stephen Webster as Class III directors for three-year terms.
- Ratified KPMG LLP as independent auditor for fiscal year 2026 with 53.7M votes for, 36.8K against.
- Advisory vote on executive compensation approved with 48.5M for, 1.1M against.

## SEC filing metadata
- accession: 0001193125-26-272890
- form_type: 8-K
- ticker: CGEM
- cik: 0001789972
- company_name: Cullinan Therapeutics, Inc.
- filed_at: 2026-06-16T21:18:15+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1789972/000119312526272890/0001193125-26-272890-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1789972/000119312526272890/cgem-20260616.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-272890
- JSON: https://secwatch.observer/filing/0001193125-26-272890.json
- Plain text: https://secwatch.observer/filing/0001193125-26-272890.txt

## Key facts
- Shareholder Votes
  Cullinan Therapeutics, Inc. shareholders approved Ratification of Appointment of KPMG LLP as Independent Registered Public Accounting Firm at the 2026-06-16 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-16
  source text: The Company's stockholders ratified the appointment of KPMG LLP as the Company's independent registered accounting firm for the fiscal year ending December 31, 2026 by the following votes: Votes For Votes Against Abstentions Broker Non-Votes 53,722,477 36,815 3,138 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1789972/000119312526272890/0001193125-26-272890-index.htm
- Shareholder Votes
  Cullinan Therapeutics, Inc. shareholders approved Election of Class III Directors at the 2026-06-16 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-16
  source text: The Company's stockholders elected two Class III directors to the Company's Board of Directors for three-year terms or until his successor has been duly elected and qualified, or until his earlier death, resignation or removal, by the following votes: Nominee Votes For Votes Withheld Broker Non-Votes Nadim Ahmed 37,519,241 12,116,759 4,126,430 Stephen Webster 36,963,086 12,672,914 4,126,430
  evidence_url: https://www.sec.gov/Archives/edgar/data/1789972/000119312526272890/0001193125-26-272890-index.htm
- Shareholder Votes
  Cullinan Therapeutics, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2026-06-16 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-06-16
  source text: The Company's stockholders approved the advisory vote on the compensation of the Company's named executive officers by the following votes: Votes For Votes Against Abstentions Broker Non-Votes 48,536,734 1,092,209 7,057 4,126,430
  evidence_url: https://www.sec.gov/Archives/edgar/data/1789972/000119312526272890/0001193125-26-272890-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.